Institute of Forest Biotechnology forestbiotech.org


The institute works for societal, ecological, and economic benefits from the appropriate uses of biotechnology in forestry worldwide. The company's cornerstone programs are Heritage Trees, Ecological Ramifications, Societal Issues and Outreach.

The institute works for societal, ecological, and economic benefits from the appropriate uses of biotechnology in forestry worldwide. The company's cornerstone programs are Heritage Trees, Ecological Ramifications, Societal Issues and Outreach.

Company (Alive / Active)

Phone:

Fax:

Raleigh, 27606
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Institute of Forest Biotechnology $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Institute of Forest Biotechnology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

AgaPharm

Ontario, United States
Alive / ActiveAgaPharm is developing a prescription eye drop for Diabetics. The drug aims to offer a simple, low-cost treatment that can deliver a safe and effective dose to the eye, preventing or slowing down the onset of diabetic blindness and cataract. The company's Research Partner is the Biotechnology Research Institute at the National Research Council of the Government of Canada.Login to see details

TaiGen Biotechnology

Taipei, Taiwan
IPO / Went publicTaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. TaiGen has a wholly-owned Beijing subsidiary with a proven capacity to conduct clinical trials and related registrations.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)